Enliven Therapeutics, Inc. (ELVN)
27.72
+0.51
(+1.87%)
USD |
NASDAQ |
Jan 22, 09:58
Enliven Therapeutics Price: 27.72 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Coherus Oncology, Inc. | 1.64 |
| Allogene Therapeutics, Inc. | 1.67 |
| Pyxis Oncology, Inc. | 1.72 |
| CEL-SCI Corp. | 5.70 |
| AIM ImmunoTech, Inc. | 1.18 |
Price Related Metrics
| Price to Book Value | 3.455 |
| Earnings Yield | -6.66% |
| Market Cap | 1.645B |